Toggle light / dark theme

Is de-extinction realistic?

Scientists in the US and Australia have announced a multi-million dollar project — resurrecting the extinct Tasmanian tiger. The last known marsupial officially called a thylacine, died in the 1930s. According to the team, the extinct thylacine can be recreated using stem cells and gene-editing technology, and the first one could be “reintroduced” to the wild within 10 years.

We would strongly advocate that first and foremost we need to protect our biodiversity from further extinctions, but unfortunately we are not seeing a slowing down in species loss.


TIGGR Lab.

Speaking at the Longevity Leaders conference earlier this year, King’s College London Professor Georgina Ellison-Hughes shared a fascinating insight into her work to establish the adult heart as a self-renewing organ with regenerative capacity.

Longevity. Technology: The heart is generally considered a “post-mitotic” organ, or one without regenerative capacity. As we age and encounter chronic disease, senescent cells accumulate in the heart, just as they do in other tissues and organs. Ellison-Hughes’ work has shown that cellular senescence may impact the efficacy of regenerative therapies, and that senolytics have the potential to rejuvenate the heart’s capacity to regenerate. We caught up with the professor to learn more.

Cellular senescence is one of the nine hallmarks of aging. It occurs when our cells stop reproducing and enter a zombie state where they refuse to die – hanging around and causing problems throughout our bodies. Ellison-Hughes is professor of regenerative muscle physiology at King’s and in 2019 was co-author of a study in Aging Cell, which found that senescent cells impaired regeneration in the human heart.

Iron could massively boost ocean algae populations.

Scientists suggest we could fertilize the world’s oceans with iron to fight climate change. Iron would lead to phytoplankton blooms, which would help to pull carbon dioxide out of the atmosphere.

One “very conservative” estimate suggests a gigaton of carbon dioxide could be removed per year with this method.

Scientists have hatched a plan to flood the world’s oceans with phytoplankton in a bid to avoid the worst effects of climate change.

Circular ribonucleic acids (circRNAs) are a promising platform for gene expression studies as a stable and prevalent ribonucleic acid in eukaryotic cells, which arise from back-splicing. In a new report now published in Nature Biotechnology, Robert Chen and a team of interdisciplinary researchers at Stanford University, California, U.S., developed a systematic approach to rapidly assemble and test features affecting protein production based on synthetic circular RNAs. The team maximized translation of the circRNA by optimizing fine elements to implement design principles to improve circular RNA yield by several hundred-fold. The outcomes facilitated an increased translation of the RNA of interest, when compared to messenger RNA (mRNA) levels, to provide durable translation in vivo.

Developing circular RNA (circRNA) in the lab

Therapeutics based on ribonucleic acids span across messenger RNA (mRNA), small interfering RNAs (siRNA) and microRNAs (miRNA) with expansion into modern medicine including small molecules, biologics and cell therapeutics. For example, the lately popular mRNA vaccines can be designed in the lab and developed at a rapid pace to respond to evolving and urgent medical crises. Coding RNAs can be circularized into circRNAs to extend the duration of protein translation, based on RNA molecules that covalently join head-to-tail. Bioengineers have also advanced the synthesis of circular long transcripts into circRNAs. However, the fundamental mechanisms of initiating translation to form circular RNA or messenger RNA differ due to the lack of a 7-methylguanylate (M7G) cap on the circular RNAs. As a result of this, researchers need to thoroughly examine the principles of circular RNA translation to build better therapies and potentially surpass the translational capacities of mRNA.

The chip is an artificial neuron, but nothing like previous chips built to mimic the brain’s electrical signals. Rather, it adopts and adapts the brain’s other communication channel: chemicals.

Called neurotransmitters, these chemicals are the brain’s “natural language,” said Dr. Benhui Hu at Nanjing Medical University in China. An artificial neuron using a chemical language could, in theory, easily tap into neural circuits—to pilot a mouse’s leg, for example, or build an entirely new family of brain-controlled prosthetics or neural implants.

A new study led by Hu and Dr. Xiaodong Chen at Nanyang Technological University, Singapore, took a lengthy stride towards seamlessly connecting artificial and biological neurons into a semi-living circuit. Powered by dopamine, the setup wasn’t a simple one-way call where one component activated another. Rather, the artificial neuron formed a loop with multiple biological counterparts, pulsing out dopamine while receiving feedback to change its own behavior.

Somerville and John Gibbons, a genomicist at the University of Massachusetts, Amherst, independently focused on food fermentation, which helped early farmers and herders transform fresh produce and milk into products that can last months or years. Gibbons took a close look at the genome of Aspergillus oryzae, the fungus that jump-starts production of sake from rice and soy sauce and miso from soybeans.

When farmers cultivate A. oryzae, the fungus—a eukaryote, with its DNA enclosed in a nucleus—reproduces on its own. But when humans take a little finished sake and transfer it to a rice mash to begin fermentation anew, they also transfer cells of the fungal strains that evolved and survived best during the first round of fermentation.

Gibbons compared the genomes of scores of A. oryzae strains with those of their wild ancestor, A. flavus. Over time, he found, selection by humans had boosted A. oryzae’s ability to break down starches and to tolerate the alcohol produced by fermentation. “The restructuring of metabolism appears to be a hallmark of domestication in fungi,” he reported last week at Microbe 2022, the annual meeting of the American Society for Microbiology. For example, domesticated Aspergillus strains may have up to five times more copies of a gene for metabolizing starches as their ancestor—“a brilliant way for evolution to turn up this enzyme,” Wolfe says.